Nasal Surgery Clinical Trial
Official title:
A Phase IV Randomized, Single-Blind Trial of Liposomal Bupivacaine (Exparel®) for Pain Control in Costal Cartilage Harvest
The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01945502 -
Nasopharyngeal Packing and Rhinologic Surgery.
|
N/A | |
| Completed |
NCT03036605 -
The Effect of Dexamethasone Added to Bupivacain in Nasal Surgery
|
Phase 4 | |
| Enrolling by invitation |
NCT06305520 -
Medical Device Pivotal Study to Injection With SkinPlus-HYAL Implant Lidocaine vs RESTYLANE Lidocaine in of Nasolabial Folds
|
N/A | |
| Recruiting |
NCT05654311 -
Performance of EEG During Emergence Agitation in Nasal Surgery.
|
||
| Completed |
NCT04819659 -
The Effect of Pharyngeal Packing on Postoperative Gastric Volume in Patients Undergoing Nasal Surgery
|
N/A | |
| Not yet recruiting |
NCT00595608 -
Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial
|
Phase 4 | |
| Recruiting |
NCT05714540 -
Effect of Oropharyngeal Pack Soaked in Ketamine or Magnesium Sulphate on Post Operative Sore Throat After Nasal Surgery
|
Phase 4 |